Carroll Financial Associates’s Pediatrix Medical MD Stock Holding History

Carroll Financial Associates’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-127	Closed	-$5K	–	1343
2018 Q3	$5K	Hold	127	–	–	﹤0.01%	1080
2018 Q2	$5K	Hold	127	–	–	﹤0.01%	1051
2018 Q1	$7K	Sell	127 -24	-16%	-$1.32K	﹤0.01%	931
2017 Q4	$8K	Buy	151 +24	+19%	+$1.13K	﹤0.01%	887
2017 Q3	$5K	Hold	127	–	–	﹤0.01%	980
2017 Q2	$7K	Sell	127 -15	-11%	-$889	﹤0.01%	911
2017 Q1	$9K	Hold	142	–	–	﹤0.01%	865
2016 Q4	$9K	Hold	142	–	–	﹤0.01%	817
2016 Q3	$9K	Hold	142	–	–	﹤0.01%	837
2016 Q2	$10K	Hold	142	–	–	﹤0.01%	781
2016 Q1	$9K	Hold	142	–	–	﹤0.01%	790
2015 Q4	$10K	Hold	142	–	–	﹤0.01%	741
2015 Q3	$11K	Buy	142 +20	+16%	+$1.61K	﹤0.01%	704
2015 Q2	$9K	Buy	+122	New	+$8.78K	﹤0.01%	728

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carroll Financial Associates's MD Position: Q4 2018 in Review

Carroll Financial Associates sold out of Pediatrix Medical (MD) in Q4 2018, closing a stake of 127 shares — an estimated $5K sold.

Carroll Financial Associates first reported a position in MD in Q2 2015 and held it in 14 quarters. The position peaked at $11K in Q3 2015. 307 funds tracked by Wall St. Rank hold MD as of Q4 2018.

Carroll Financial Associates reported no remaining Pediatrix Medical position as of Q4 2018 after selling out during the quarter.
Carroll Financial Associates sold 127 Pediatrix Medical shares in Q4 2018, an estimated $5K.
Carroll Financial Associates first reported a position in Pediatrix Medical in Q2 2015 and held it in 14 quarters.
Carroll Financial Associates's Pediatrix Medical position peaked at $11K in Q3 2015.
307 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2018.

Based on Carroll Financial Associates's 13F filing for Q4 2018, filed 11 Jan 2019.